Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6383480

Title:Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells
Inventors:Kikuchi, Makoto; Fukuoka, Japan
Ikematsu, Shinya; Kanagawa, Japan
Oda, Munehiro; Kanagawa, Japan
Sakuma, Sadatoshi; Kanagawa, Japan
Muramatsu, Takashi; Aichi, Japan
Summary:Described herein is a novel promoter for the differentiation and growth of mammalian hematopoietic stem cells and prodromal hematopoietic cells. The invention relates to the novel use of the MK family when used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. Further disclosed is an agent for remarkably enhancing such an effect in promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO. Therapeutic applications are included, such as in the treatment of neutropenia and in the ex vivo expansion of hematopoietic stem cells in bone marrow transplantation.
Abstract:The present invention provides novel use of the MK family that is used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. The invention also provides an agent for remarkably enhancing the above-described effect for promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6383480
Application Number:US1999000214569
Date Filed:07/01/1999
Date Published:07/05/2002
Assignee:Meiji Milk Products, Co., Ltd., Tokyo, Japan


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021